View Past Agendas: 2013 | 2012| 2011 |2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004

2009 Agenda

View the photo scrapbook from Convergence 2009 and the agenda below.

Thursday, June 11th
4:30pm-5:30pm

The Shifting Winds of Policy and Regulation in the Obama Era

The Hon. David N. Cicilline, Mayor of Providence
Alan Eisenberg, EVP/Emerging Companies, BIO
Vinod Sahney, PhD, SVP and Chief Strategy Officer, Blue Cross Blue Shield of Massachusetts
Steve Usdin, Senior Editor, BioCentury

5:30pm-7:30pm Opening Cocktail Reception

7:30pm-
Dinner on the town with fellow attendees
Friday, June 12th
7:30am-8:30am Breakfast
8:45am-9:00am Welcome Connie Chow, Executive Director, Science Club for Girls
9:00am-10:15am

Fireside Chat: The Future of the Healthcare System: How are Healthcare IT, Reimbursement, and New Product Adoption Changing? (MP3 file)

Charlie Baker, CEO, Harvard Pilgrim Health Care
Paul Levy, President and CEO, Beth Israel Deaconess Medical Center

Moderator:
Jeffrey Krasner, Managing Director, Krasner Health Strategies

9:30am-12:00pm Guest Activity:
Scenic trolley tour of Newport, including historic buildings and homes, the mansions on Bellevue Avenue and ten-mile Ocean Drive
10:15am-10:45am Networking Break

10:15am-11:30am Children's Activity:
Visit the Redwood Children's Library for story time (recommended ages 3-5)
10:45am-12:00pm

The New Logic of Partnerships, Collaborations and Licensing Deals (MP3 file)

Yvonne Greenstreet, MD, Senior Vice President and Chief of R&D Strategy, GlaxoSmithKline
Reid Leonard, PhD, Executive Director of Licensing & External Research, Merck Research Laboratories, Merck & Co., Inc
Michael Lytton, MSc, Executive Vice President, Corporate and Business Development
Chuck Wilson, PhD, VP and Global Head of Strategic Alliances, Novartis Institutes for Biomedical Research

Moderator:
John Maraganore, PhD, CEO, Alnylam Pharmaceuticals

12:00pm-1:30pm Lunch

1:30pm-2:30pm

Fireside Chat: The Past, Present & Future of Genzyme (MP3 file)

Henri Termeer, CEO and Chairman, Genzyme Corp.

Moderator:
Christoph Westphal, MD, PhD, CEO, Sirtris & SVP, GlaxoSmithKline

2:30pm-3:00pm Networking Break

3:00pm-4:00pm

The Dynamics Reshaping Life Sciences Venture Capital Speakers:

Jeff Barnes, General Partner, Oxford Bioscience Partners
James Campbell, MD, Executive-in-Residence, InterWest Partners; CEO of Arcion Therapeutics
Dov Goldstein, MD, Partner, Aisling Capital
Stephen Hoffman, PhD, MD, General Partner, Skyline Ventures
Amir Nashat, PhD, General Partner, Polaris Venture Partners

Moderator:
Douglas MacDougall, President, MacDougall Biomedical Communications, Inc.

4:15pm-6:30pm Participant and Guest Activity:
Tour and tasting at Newport Vineyards
4:15pm-6:30pm Participant and Guest Activity:
Discover Colonial Newport walking tour with the Newport Historical Society
6:30pm-9:30pm Children's program:
"Under the Sea". Arts & crafts, movies and dinner.
7:00pm-10:00pm Jazz Dinner with music by The Moonlight Trio (Convergence attendees are welcome to have 1 guest join them.)
Saturday, June 13th
8:00am-9:00am Breakfast
9:00am-10:00am

Alternative Funding Sources for Life Sciences Start-Ups

Chip Baird, CFO, PTC Therapeutics
Randall Carpenter, MD, CEO, Seaside Therapeutics
John Hollway, VP/Corporate Development, Achaogen
Roger Kitterman, Co-Founder, MA Medical Angels
David Steinberg, Partner, PureTech Ventures and CEO, Enlight Biosciences

Moderator:
Alison Taunton-Rigby, PhD, OBE, CEO, RiboNovix

10:00am-10:30am Networking Break

10:30am-11:30am

Live from the Labs: Research Insights That Will Shape the Decades Ahead (MP3 file)
[This session is open to guests of registered participants.]

David Eisenberg, MD, Director of the Osher Research Center, Harvard Medical School
David Altshuler, MD, PhD, Founding Member, Broad Institute

Moderator:
Michael Gilman, PhD, CEO, Stromedix

10:30am-12:30pm Children's Activity:
Visit the Norman Bird Sanctuary for the Amazing Animals program

11:00am-12:30pm Guest Activity:
Visit the Newport Art Museum, located in the Griswold House, a national historical landmark

11:30am-11:45am Networking Break

11:45am-12:30pm

Opportunities & Challenges of Operating Globally
[This session is open to guests of registered participants.]

Lawrence Best, Chairman and Founder, OXO Capital LLC; former CFO, Boston Scientific
Elisabet de los Pinos, PhD CEO, Aura Biosciences
Edward Kerslake, Vice President, Corporate R&D, Boston Scientific
Steven Tregay, PhD, CEO, Forma Therapeutics

Moderator:
Richard Kivel, CEO, TheraGenetics

12:30pm-1:30pm Closing Lunch

1:45pm-4:00pm Participant and Guest Activity:
Enjoy the sites and sounds of Newport on a harbor cruise

*Guest activities subject to change